Robert M. Townsend - Publications

Belatacept suppresses B-cell subset alloresponses.

Journal: Human immunology

Published: October 06, 2025

Testing to Identify Submaximal Effort: Lifting to a Perceived 50% Effort vs. an Assigned Submaximal Load.

Journal: Journal of strength and conditioning research

Published: April 14, 2020

Decision-Making Data: Expectations for Reproducibility of Lifting on Separate Days.

Journal: Professional case management

Published: February 06, 2018

Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 24, 2017

Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 08, 2017

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

Journal: Lupus science & medicine

Published: January 11, 2017

Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens.

Journal: Scientific reports

Published: March 12, 2015

Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 24, 2014

Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipients.

Journal: Clinical drug investigation

Published: November 13, 2013